Kingdon Capital Management, L.L.C. is an SEC-registered investment adviser based in New York, NY that reports managing 7 hedge funds on Form ADV. It reports $959.8 million in regulatory assets under management. Its private funds, of all types, hold $1.7 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated +18.9% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +45.3% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $959.8 millionForm ADV Item 5.F
- Gross assets of private funds
- $1.7 billionAll private fund types, Form ADV
- Hedge funds managed
- 78 private funds in total
- Employees
- 19Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 157509
- Latest Form ADV
- 10/05/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +22.3% | +14.8% |
| Q1 2026 | -2.8% | -4.6% |
| Q4 2025 | +3.9% | +2.4% |
| Q3 2025 | +16.5% | +7.8% |
| Q2 2025 | +10.9% | +10.4% |
| Q1 2025 | -12.1% | -4.5% |
| Q4 2024 | -3.9% | +2.1% |
| Q3 2024 | +7.9% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.
13F holdings as of Sep 30, 2026
The 50 largest of 52 share positions ($671,872,319) reported by Kingdon Capital Management, L.L.C. on Form 13F for the quarter ended Sep 30, 2026, filed Nov 16, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.
Share of the reported 13F portfolio, ten largest positions
- Nvidia Corporation6.97%
- Grail Inc6.67%
- Syndax Pharmaceuticals Inc6.28%
- Warby Parker Inc5.07%
- Intuitive Surgical Inc3.37%
- Keysight Technologies Inc3.25%
- Api Group Corp3.02%
- Hims & Hers Health Inc2.77%
- Nexgen Energy LTD2.73%
- Darling Ingredients Inc2.44%
| Stock | Value | % of 13F portfolio | Shares | Shares vs prior quarter |
|---|---|---|---|---|
| Nvidia Corporation | $46,817,900 | 6.97% | 205,000 | -14.58% |
| Grail Inc | $44,838,400 | 6.67% | 320,000 | -5.88% |
| Syndax Pharmaceuticals Inc | $42,206,000 | 6.28% | 2,245,000 | -10.20% |
| Warby Parker Inc | $34,076,170 | 5.07% | 1,226,644 | +8.88% |
| Intuitive Surgical Inc | $22,649,291 | 3.37% | 55,700 | +50.13% |
| Keysight Technologies Inc | $21,842,400 | 3.25% | 60,000 | -14.29% |
| Api Group Corp | $20,265,000 | 3.02% | 525,000 | -12.50% |
| Hims & Hers Health Inc | $18,597,242 | 2.77% | 624,278 | +15.07% |
| Nexgen Energy LTD | $18,349,440 | 2.73% | 2,012,000 | -19.52% |
| Darling Ingredients Inc | $16,391,700 | 2.44% | 270,000 | +100.00% |
| Quanta Svcs Inc | $16,062,750 | 2.39% | 25,000 | +56.25% |
| Taiwan Semiconductor Manufac | $15,966,650 | 2.38% | 35,000 | -22.22% |
| Howmet Aerospace Inc | $15,832,600 | 2.36% | 70,000 | +16.67% |
| Icon Pub LTD Co | $15,350,097 | 2.28% | 90,300 | New |
| Everus Constr Group | $15,277,600 | 2.27% | 130,000 | +4.00% |
| Teledyne Technologies Inc | $15,170,250 | 2.26% | 25,000 | Unchanged |
| Itt Inc | $15,136,500 | 2.25% | 75,000 | +50.00% |
| Alibaba Group Hldg LTD | $15,055,600 | 2.24% | 140,000 | +40.00% |
| Parker-hannifin Corp | $14,331,300 | 2.13% | 15,000 | New |
| SM Energy Company | $14,187,600 | 2.11% | 420,000 | New |
| Heico Corp New | $13,643,100 | 2.03% | 45,000 | +50.00% |
| American Healthcare REIT Inc | $13,583,900 | 2.02% | 265,000 | +51.43% |
| Maplebear Inc | $12,936,000 | 1.93% | 300,000 | -21.05% |
| Fedex Corp | $12,829,050 | 1.91% | 45,000 | +28.57% |
| Cognex Corp | $12,736,500 | 1.90% | 210,000 | +5.00% |
| Brookdale SR Living Inc | $11,371,500 | 1.69% | 1,050,000 | +31.25% |
| F5 Inc | $11,129,500 | 1.66% | 25,000 | +108.33% |
| Wolverine World Wide Inc | $10,701,600 | 1.59% | 560,000 | +15.46% |
| Olema Pharmaceuticals Inc | $10,368,000 | 1.54% | 1,200,000 | Unchanged |
| Walmart Inc | $9,872,400 | 1.47% | 95,000 | New |
| Meta Platforms Inc | $9,789,930 | 1.46% | 13,500 | New |
| Crane Company | $9,180,900 | 1.37% | 45,000 | +12.50% |
| Genesco Inc | $8,330,160 | 1.24% | 244,000 | Unchanged |
| Vicor Corp | $7,945,850 | 1.18% | 27,500 | +10.00% |
| Flex LTD | $7,699,300 | 1.15% | 70,000 | -22.22% |
| Beam Therapeutics Inc | $7,569,720 | 1.13% | 309,600 | New |
| The Realreal Inc | $7,186,920 | 1.07% | 813,000 | Unchanged |
| Himax Technologies Inc | $7,035,000 | 1.05% | 500,000 | New |
| Vse Corp | $6,999,750 | 1.04% | 42,500 | -19.05% |
| Bank Of Amer Corp | $6,803,750 | 1.01% | 125,000 | New |
| Brightspring Health Svcs Inc | $6,117,650 | 0.91% | 107,800 | New |
| Lionsgate Studios Corp | $5,600,000 | 0.83% | 500,000 | +33.33% |
| Inventiva SA | $5,535,000 | 0.82% | 1,500,000 | +18.11% |
| Welltower Inc | $4,604,800 | 0.69% | 20,000 | -20.00% |
| Proem Acquisition Corp I | $3,000,000 | 0.45% | 300,000 | New |
| Aldeyra Therapeutics Inc | $2,954,847 | 0.44% | 2,402,315 | -9.43% |
| Butterfly Network Inc | $2,867,200 | 0.43% | 320,000 | -81.18% |
| Niocorp Devs LTD | $1,620,000 | 0.24% | 450,000 | Unchanged |
| Scynexis Inc | $1,224,186 | 0.18% | 247,811 | Unchanged |
| Pyxis Oncology Inc | $1,165,000 | 0.17% | 500,000 | New |
Changes since Jun 30, 2026
Comparing the share counts in the two quarter-end filings: 11 new positions, 16 sold out, 20 increased, 13 reduced and 8 unchanged.
Number of positions (a count, not dollars)
- New positions11
- Increased20
- Unchanged8
- Reduced13
- Sold out16
New positions
| Stock | Value | Shares |
|---|---|---|
| Icon Pub LTD Co | $15,350,097 | 90,300 |
| Parker-hannifin Corp | $14,331,300 | 15,000 |
| SM Energy Company | $14,187,600 | 420,000 |
| Walmart Inc | $9,872,400 | 95,000 |
| Meta Platforms Inc | $9,789,930 | 13,500 |
| Beam Therapeutics Inc | $7,569,720 | 309,600 |
| Himax Technologies Inc | $7,035,000 | 500,000 |
| Bank Of Amer Corp | $6,803,750 | 125,000 |
| Brightspring Health Svcs Inc | $6,117,650 | 107,800 |
| Proem Acquisition Corp I | $3,000,000 | 300,000 |
| Pyxis Oncology Inc | $1,165,000 | 500,000 |
Sold out
| Stock | Value at Jun 30, 2026 | Shares held then |
|---|---|---|
| Fluence Energy Inc | $17,892,000 | 900,000 |
| Illumina Inc | $17,196,174 | 97,800 |
| Garrett Motion Inc | $13,586,250 | 375,000 |
| Cytokinetics Inc | $13,383,349 | 157,100 |
| Zevra Therapeutics Inc | $11,113,500 | 775,000 |
| Ralliant Corp | $11,044,500 | 150,000 |
| Invesco Exch Traded FD TR II | $10,351,250 | 175,000 |
| Aercap Holdings NV | $10,204,600 | 70,000 |
| Ge Aerospace | $9,343,250 | 25,000 |
| Entegris Inc | $8,993,000 | 50,000 |
| Aar Corp | $7,503,825 | 52,500 |
| Delta Air Lines Inc | $7,211,820 | 77,000 |
| Credo Technology Group Holdi | $5,846,925 | 21,500 |
| Eledon Pharmaceuticals Inc | $4,094,744 | 1,039,275 |
| Compass Inc | $3,082,500 | 250,000 |
| Compass Therapeutics Inc | $3,066,000 | 1,400,000 |
Largest increases
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Darling Ingredients Inc | +135,000 | +100.00% | $16,391,700 | 270,000 |
| Intuitive Surgical Inc | +18,600 | +50.13% | $22,649,291 | 55,700 |
| F5 Inc | +13,000 | +108.33% | $11,129,500 | 25,000 |
| Quanta Svcs Inc | +9,000 | +56.25% | $16,062,750 | 25,000 |
| Itt Inc | +25,000 | +50.00% | $15,136,500 | 75,000 |
| American Healthcare REIT Inc | +90,000 | +51.43% | $13,583,900 | 265,000 |
| Heico Corp New | +15,000 | +50.00% | $13,643,100 | 45,000 |
| Alibaba Group Hldg LTD | +40,000 | +40.00% | $15,055,600 | 140,000 |
| Fedex Corp | +10,000 | +28.57% | $12,829,050 | 45,000 |
| Warby Parker Inc | +100,000 | +8.88% | $34,076,170 | 1,226,644 |
| Brookdale SR Living Inc | +250,000 | +31.25% | $11,371,500 | 1,050,000 |
| Hims & Hers Health Inc | +81,778 | +15.07% | $18,597,242 | 624,278 |
| Howmet Aerospace Inc | +10,000 | +16.67% | $15,832,600 | 70,000 |
| Wolverine World Wide Inc | +75,000 | +15.46% | $10,701,600 | 560,000 |
| Lionsgate Studios Corp | +125,000 | +33.33% | $5,600,000 | 500,000 |
| Crane Company | +5,000 | +12.50% | $9,180,900 | 45,000 |
| Inventiva SA | +230,000 | +18.11% | $5,535,000 | 1,500,000 |
| Vicor Corp | +2,500 | +10.00% | $7,945,850 | 27,500 |
| Cognex Corp | +10,000 | +5.00% | $12,736,500 | 210,000 |
| Everus Constr Group | +5,000 | +4.00% | $15,277,600 | 130,000 |
Largest reductions
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Butterfly Network Inc | -1,380,000 | -81.18% | $2,867,200 | 320,000 |
| Nvidia Corporation | -35,000 | -14.58% | $46,817,900 | 205,000 |
| Syndax Pharmaceuticals Inc | -255,000 | -10.20% | $42,206,000 | 2,245,000 |
| Taiwan Semiconductor Manufac | -10,000 | -22.22% | $15,966,650 | 35,000 |
| Nexgen Energy LTD | -488,000 | -19.52% | $18,349,440 | 2,012,000 |
| Keysight Technologies Inc | -10,000 | -14.29% | $21,842,400 | 60,000 |
| Maplebear Inc | -80,000 | -21.05% | $12,936,000 | 300,000 |
| Api Group Corp | -75,000 | -12.50% | $20,265,000 | 525,000 |
| Grail Inc | -20,000 | -5.88% | $44,838,400 | 320,000 |
| Flex LTD | -20,000 | -22.22% | $7,699,300 | 70,000 |
| Vse Corp | -10,000 | -19.05% | $6,999,750 | 42,500 |
| Welltower Inc | -5,000 | -20.00% | $4,604,800 | 20,000 |
| Aldeyra Therapeutics Inc | -250,000 | -9.43% | $2,954,847 | 2,402,315 |
Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.
From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures
Large ownership stakes (Schedule 13D and 13G)
| Company | Filing | Percent of class | Shares | Filed | Source |
|---|---|---|---|---|---|
| enVVeno Medical Corporation | 13G amendment | 5.5% | 36,166 | May 15, 2026 | SEC.gov ↗ |
| Scynexis Inc | 13G amendment | 0% | 0 | Feb 17, 2026 | SEC.gov ↗ |
| Jasper Therapeutics, Inc. | 13G amendment | 4.7% | 1,324,845 | Nov 12, 2025 | SEC.gov ↗ |
A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Nov 12, 2025, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.
Hedge funds filing Form D (3)
Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.
Private funds reported on Form ADV (2)
As reported in the adviser's Form ADV filed Sep 13, 2024. Funds also listed from Form D are shown above.
Fund vehicles: feeder funds and single-deal vehicles (5)
Feeder funds invest through a master fund; single-deal vehicles (SPVs, co-investments, series) hold one investment.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures